Sana Biotechnology
A Senior Director at Sana Biotechnology leads late-stage process development for cell therapy products, ensuring scalability, regulatory compliance, and commercial readiness. The role involves managing a team, collaborating across departments, and advancing clinical and commercial pipelines.
Headquarters
Seattle, Washington, United States
Company Size
201-500 employees
Founded
2018
Sana Biotechnology engineers cells to repair or control genes in diseased cells or to replace missing or damaged cells, aiming to address the underlying causes of disease. The company develops cell- and gene-based therapeutic platforms — spanning in vivo and ex vivo approaches — to create durable, curative treatments across a range of indications. Sana combines platform R&D with preclinical and clinical programs to advance engineered-cell medicines toward scalable, restorative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sana Biotechnology.
30% above the average for this role
Sana Biotechnology to Present at March 2026 Investor Conferences
3 weeks ago
Stem Cell Scientist
Conception
Associate Scientist R&D (Cell Culture)
Cepheid
Associate Director, Late-Stage Cell Therapy Process Development
AstraZeneca
Senior Scientist, Engineering- Cell Banking
MSD
Associate Scientist R&D (Cell Culture)
Cepheid
Associate Director, Viral Vector Process Development, Upstream
AstraZeneca